NEW YORK, NY – December 4, 2025 – MM+M has announced its seventh class of 40 Under 40 honorees, recognizing Mike Gelber, Chief Product Officer at Impiricus, the #1 fastest growing company in North America according to Deloitte. Gelber is honored for pioneering the future of ethical physician-pharma collaboration through the launch of Impiricus Ascend, an AI-powered communication platform that is fundamentally changing how healthcare professionals (HCPs) access critical resources.
The MM+M 40 Under 40 list celebrates young leaders whose strategic thinking and digital facility contribute significantly to the healthcare industry’s growth.
“The individuals on the list are laying the foundation upon which the future of this industry will be built. They are creating a more equitable, inclusive landscape that will help pharma and biotech companies reach all patient populations,” said MM+M editor-in-chief Jameson Fleming.
Mike Gelber is the product visionary behind Ascend, Impiricus’ flagship platform that resolves the physician pain point of information overload and accelerates patient access to care. Ascend is the solution for meeting HCPs where they are, cutting through the noise with personalized, efficient, and ethical pharma resource delivery.
The platform is powered by proprietary AI models trained on over four billion HCP data points. Ascend leverages a unique, agentic AI delivery system with secure, tokenized data pipelines to amplify access to pharma resources for underserved physicians. This secure mobile-first experience allows physicians to connect with a representative in real-time and access essential resources like samples, treatment information, and dosing calculators.
“Mike Gelber’s dedication to AI innovation for ethical, HCP engagement is transforming how the pharma industry supports providers. Physicians report that these connections are helping patients access critical medications faster without the time burden of the traditional pharma model,” said Dr. Osama Hashmi, Dermatologist, CEO and Co-founder of Impiricus.
Impiricus has now been named the #1 fastest growing company in North America by the Deloitte Fast 500.
About Impiricus
Impiricus is the first and only AI-powered HCP Engagement Engine. Founded by a practicing physician and a senior pharmaceutical executive, Impiricus was created to transform how life sciences companies support physicians. We ethically connect HCPs to pharma resources, reduce go-to-market costs and accelerate patient access to the treatments they need.
With our unique access to the largest opted-in network of HCPs, their insights, and clinical expertise, we are the leading provider of AI technology and real-time channels that life science companies need to deliver clear, reliable, and evidence-based resources directly into the hands of HCPs.
Guided by a council of 2000+ trusted HCP advisors, we ensure every interaction is clinically meaningful, ethically grounded and leads to better patient care.
Partner with us:
https://impiricus.com/contact-us/
